MASHINIi

Hyperfine, Inc..

HYPR.US | Manufacture of irradiation, electromedical and electrotherapeutic equipment

Hyperfine, Inc. is a medical technology company focused on reinventing magnetic resonance imaging (MRI). They develop and market portable, low-cost MRI systems designed for point-of-care imaging. Their products aim to make MRI more accessible and affordable, enabling clinicians to rapidly diagnose p...Show More

Ethical Profile

Mixed.

Hyperfine, Inc. aims to boost global health access with its portable Swoop MRI system, supported by a $3.3 million Bill & Melinda Gates Foundation grant for 25 deployments in developing countries. The FDA cleared the system in 2021. However, reports suggest mixed employee sentiment, with Glassdoor reviews averaging 2.8/5 stars and only 35% recommending the company. Critics point to layoffs, poor management, and understaffing, with compensation ratings reportedly decreasing 12%. Hyperfine complies with GDPR, CCPA, and PIPEDA, holding HITRUST CSF®, ISO 13485:2016, and SOC 2 Type II certifications.

Value Scores

Better Health for All20
-100100
Fair Money & Economic Opportunity0
-100100
Fair Pay & Worker Respect-10
-100100
Fair Trade & Ethical Sourcing0
-100100
Honest & Fair Business-40
-100100
Kind to Animals-40
-100100
No War, No Weapons0
-100100
Planet-Friendly Business-20
-100100
Respect for Cultures & Communities0
-100100
Safe & Smart Tech10
-100100
Zero Waste & Sustainable Products0
-100100

Better Health for All

20

The company's core product, the FDA-cleared Swoop® portable MRI system, delivers revolutionary health benefits by making MR imaging accessible, reducing MRI wait times by an average of 18 hours, and accelerating diagnosis for neurological conditions.

1
The system achieved 100% sensitivity and specificity for lesions greater than 1.0 mL and can detect lesions as small as 2.8 mm.
2
The company has no products with significant negative health impacts. The Swoop system has an outstanding safety record, improving safety by using an ultra-low-field environment, eliminating ionizing radiation, and reducing adverse events during patient transport, with its predicate device not subject to a design-related recall.
3
The Swoop system is more cost-effective to own and maintain than conventional high-field MRI systems, eliminating an average cost of $590 per patient for transitioning to MR-compatible equipment, and is eligible for CMS reimbursement.
4
The company targets remote communities and low-resource countries, deploying 25 Swoop systems in Europe, Asia, and Sub-Saharan Africa to assess early brain development in children in low- and middle-income countries, where over 90% of the world lacks access to MRI.
5
The company provides excellent risk transparency, disclosing risks of transport-related adverse events and ensuring the Swoop system complies with EMC emission standards.
6
Hyperfine has received $4.9 million in grants from the Bill & Melinda Gates Foundation to expand the use of portable MRI technology in developing countries.
7
The company securely uploads images to facility PACS or a HIPAA-compliant Image Viewer with unlimited storage.
8
The Swoop system is designed to enhance comfort and reduce patient anxiety with its open design and quieter operation, allowing family to stay by the patient’s side.
9
The company conducts multi-center, prospective observational studies, such as the NEURO PMR study, to evaluate clinical utility and patient experience.
10

Fair Money & Economic Opportunity

0

Hyperfine, Inc. is a medical technology company that develops and markets portable MRI systems.

1
Its business model involves selling and servicing these medical devices. The ethical value 'Fair Money & Economic Opportunity' is designed to assess financial institutions and companies involved in lending, insurance, or other financial services. As Hyperfine, Inc. does not offer any financial products or services, none of the KPIs in this rubric are applicable to its operations.
2
Therefore, no KPIs can be scored based on the provided articles or the company's core business.

Fair Pay & Worker Respect

-10

The company's employee rating on Glassdoor is 2.8 out of 5 stars, which translates to an engagement score of 56/100.

1
Additionally, only 35% of employees would recommend working at the company.
2
There are no specific regulatory actions, violations, fines, or compliance issues mentioned in the provided articles regarding labor laws or human rights.
3

Fair Trade & Ethical Sourcing

0

No specific, concrete evidence was found in the provided articles to score Hyperfine, Inc. against any of the KPIs for the 'Fair Trade & Ethical Sourcing' value. The articles either indicated an inability to access content or explicitly stated a lack of quantitative data, regulatory actions, violations, fines, or certifications relevant to the scoring rubric.

1

Honest & Fair Business

-40

The company reported one financial restatement of HealthCor's initial carrying value of Class A ordinary shares due to misclassification, which represented a material weakness in internal controls over financial reporting.

1
The board of directors consists of six members, with three determined to be independent, resulting in 50% independent directors.
2
Jonathan M. Rothberg, Ph.D. beneficially owns 100% of the Class B common stock and controls 84.7% of the voting power.
3
The company is required to comply with anti-bribery laws, such as the U.S. Foreign Corrupt Practices Act, but the articles do not provide details on the strength or enforcement of its anti-corruption policy beyond this requirement.
4

Kind to Animals

-40

The company promotes compliance with applicable governmental laws, rules, and regulations.

1
This general statement does not indicate a public position on animal welfare legislation or active engagement in advocating for higher standards.

No War, No Weapons

0

Hyperfine, Inc. operates in the healthcare sector, developing and marketing portable MRI systems.

1
The company's core business is explicitly stated as being in healthcare, not arms or defense.
2
There is no evidence of revenue from arms or defense contracts, involvement in dual-use technologies with military applications, sales to embargoed regimes, or any other activities related to the arms trade or military.
3
The company's AI software is for medical imaging, not military use.
4
Its global health initiatives, such as a $3 million grant for clinical research on childhood malnutrition in low and middle-income countries, are humanitarian in nature, not peacebuilding or disarmament.
5
Therefore, all KPIs related to war, weapons, or conflict are not applicable to Hyperfine, Inc.'s core operations as described in the provided articles.

Planet-Friendly Business

-20

The company has no reported environmental compliance violations, fines, or regulatory actions.

1
It operates a recycling program for retired Swoop® system prototypes and research system housings, partnering with a recycling center to keep PVC housings out of landfills.
2
However, no specific waste diversion percentage for the company is provided.
3
There is no mention of science-based carbon reduction targets, capital expenditure aligned with the EU Sustainable Taxonomy, or climate-positive initiatives.
4
The company also does not report on its total greenhouse gas emissions, renewable energy use, or water consumption.
5

Respect for Cultures & Communities

0

No specific, concrete data points were found in the provided articles for any of the KPIs related to 'Respect for Cultures & Communities'. The articles discuss Hyperfine's global health initiatives, grants received for improving access to brain imaging in low-resource settings,

1
and collaborations with international societies,
2
but they do not provide quantifiable evidence for metrics such as formal partnerships with indigenous or local community groups, cultural appropriation incidents, local employment ratios, or the existence of cultural impact assessment protocols.

Safe & Smart Tech

10

Hyperfine, Inc. holds several key certifications, including HITRUST CSF® v9.4 Risk-based, 2-year (r2) certification, ISO 13485:2016 for the design, development, manufacture, and service of MRI devices, PACS, and radiology software, and a SOC 2 Type II report for its Swoop® system.

1
The company's privacy notice outlines user rights for data access, deletion, and correction for residents in the EEA, UK, Switzerland, California, and Canada.
2
It also mentions minimizing the collection of personal information where not required and states compliance with GDPR, CCPA, PIPEDA, and other relevant regulations.
3

Zero Waste & Sustainable Products

0

No evidence available to assess Hyperfine, Inc. on Zero Waste & Sustainable Products.

Own Hyperfine, Inc.?

Upload your portfolio and see how all your holdings score across 11 ethical dimensions.

Audit My Portfolio

AI-generated analysis based on publicly available data. Not financial advice. Ratings are expressions of opinion derived from automated models and may contain inaccuracies. See our Risk Disclosure for full details.